A new Journal of Neuroscience study reports elevated levels of BACE1, an enzyme associated with neuronal damage in Alzheimer's disease, were identified in postmortem brain samples of those with HIV.
A new study has pinpointed a catalytic trigger for the onset of Alzheimer's disease. The findings could play a central role in the diagnostics and new drug development for neurodegenerative diseases.
Researchers reveal a compound in green tea extract may help protect the brain against cognitive decline associated with Alzheimer's by coating toxic oligomers.
A new study reports a molecular chaperone can inhibit a key stage in the development of Alzheimer's disease.
With the help of the Gordon supercomputer, researchers discover new ways to elucidate the creation of oligomers associated with Alzheimer's.
Researchers have discovered how synthetic molecules latch onto amyloid peptide fibrils. The discovery could help develop new therapies to halt Alzheimer's disease.
A new study reports disrupted transportation routes in nerve cells are a significant cause of Parkinson's disease.
Raman spectroscopy techniques allows researchers to take a closer look at the elusive amyloid beta.
Researchers report memantine, an FDA approved drug, may not only alleviate symptoms of mild Alzheimer's disease, but could also prevent progression of the disease if used before symptoms appear.
The protein beta-arrestin-2 increases tau tangle accumulation in Alzheimer's disease and frontotemporal dementia but interfering with the removal of excess tau from the brain.
Researchers have invented a probe that lights up when it binds to a misfolded amyloid peptide.
Researchers have developed a new imaging technique that makes it possible to study why proteins associated with Alzheimer’s and Parkinson’s diseases may go from harmless to toxic.
